Topic prioritisation
Showing 1 to 2 of 2
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094] | None selected | Not selected | |
| Image-guided high intensity focused ultrasound to treat breast cancer | None selected | Not selected |